Liver Disease Clinical Trials

Showing 1101-1120 of 1,279 trials

Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection

NCT02329821

The investigators are trying to investigate metabolism of lactate sourced from IV Hartmann's solution in patients with hepatocellular carcinoma(HCC) compared with a control group(donation for liver transplantation) with normal liver function. Second purpose of this study is finding the predictive factor of changing metabolism of lactate sourced from IV Hartmann's solution in patients with HCC.

Hepatocellular CarcinomaLiver Disease

Samsung Medical Center72 participantsStarted Nov 2014

Seoul, South Korea

COMPLETEDPhase 3

Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption

NCT02200029

A research study of an approved drug called Heptral®, ademetionine, to treat adults with intrahepatic cholestasis (a condition where bile cannot flow from the liver to the duodenum) in pre-cirrhotic and cirrhotic states. Experience from clinical studies in subjects with liver disease has shown that ademetionine is effective.

Intrahepatic Cholestasis Associated With Alcoholic Liver Disease

Abbott75 participantsStarted Jun 2014

Moscow, Russia • Moscow, Russia • Moscow, Russia +9 more locations

Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection

Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption

Related Searches

Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin

Vitamin D Supplementation in Cirrhotic Patients

Meta-analyses of Fructose and Cardiometabolic Risk

Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure

Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors

Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease

Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis

Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis

Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients

Protein-rich Diet and NAFLD in Bariatric Surgery

Total Parenteral Nutrition-Associated Liver Disease

Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding

Single Pass Albumin Dialysis in Patients With Cirrhosis

To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease

Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects

CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment

Bioelectrical Impedance Vector Analysis in Cirrhotic Patients